Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2CNS 1

Conditions

Spinal Cord Neoplasms 1Osteosarcoma 1Bone Neoplasms 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Fluoridation × Clear all
NCT04410042 2024-12-20

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

St. Jude Children's Research Hospital

Phase 3 Terminated
15 enrolled 13 charts
Sarcoma

Bone Neoplasms

NCT05024253 2024-02-07

Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.

Children's Cancer Hospital Egypt 57357

Phase 3 Completed
48 enrolled
Sarcoma

Osteosarcoma

NCT05493228 2022-08-09

Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients

Children's Cancer Hospital Egypt 57357

Phase 3 Unknown
38 enrolled
CNS

Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡